Certification is a compulsory independent assessment procedure for the quality and safety of care in public and private hospitals. It is conducted every 4 years by professionals (peers) appointed by the HAS (surveyors).

  The objective of the European taskforce is to reach a mutual understanding between competent agencies with competences in health technology assessment for digital medical devices (DMDs) at national level, in order to harmonise the assessment criteria  in the European Union. The first results of the three work packages were presented at the Digital Medicine Conference in Luxembourg on October 26-27.

September 17 th is the World Patient Safety Day . The theme chosen by the World Health Organization (WHO) for the 2022 edition is “Medication without harm”. On this occasion, we mark the importance in raising awareness on major issues affecting quality and safety of care – area of focus which falls within HAS’s scope of action.

Three types of measures are used to assess quality of care as perceived by patients, using different tools: Patient-Reported Outcome Measures (PROMs) for care outcomes, Patient-Reported Experience Measures (PREMs) for the care experience and patient satisfaction questionnaires to assess meeting of their expectations. Based on research published in the literature and numerous illustrations, this report describes the theoretical foundations and methodological approaches, accompanied by practical cases, as well as the challenges relative to quality of care that could be met by proficiency in the use of these solutions. In particular, the aim is to improve communication between patients and professionals, personalise care and more effectively monitor patients' health.

HAS’s work programme is defined each year at the end of a programming procedure carried out in consultation with the Ministry of Solidarity and Health and the National Health Insurance fund.

The Transparency Committee (TC) of the French National Authority for Health (HAS) is responsible for the scientific and medical assessment of medicinal products when pharmaceuticals companies submit applications to the French Minister of Health for registration on the lists of medicinal products reimbursed by National Health Insurance.